Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
1. Diquafosol
2. Ins 365
3. Ins-365
4. Ins365
1. 211427-08-6
2. Ins365
3. Up4u
4. Diquafosol Sodium
5. Kpy-998
6. De-089
7. X8t9sbh9ll
8. Diquafosol Tetrasodium Salt
9. Diquafosol Tetrasodium [usan]
10. Diquafosol Sodium (jan)
11. Tetrasodium;[[(2r,3s,4r,5r)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] [[[(2r,3s,4r,5r)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl]oxy-oxidophosphoryl] Phosphate
12. Diquafosol Tetrasodium (usan)
13. Uridine(5')tetraphospho(5')uridine Tetrasodium Salt
14. Diquafosol (tetrasodium)
15. Diquafosol Sodium [jan]
16. Chembl1767408
17. Ins-365
18. Prolacria
19. Diquas
20. Unii-x8t9sbh9ll
21. Ins365 Ophthalmic Solution
22. U2p4
23. Ex-a6122
24. Diquafosol Tetrasodium [mart.]
25. Diquafosol Tetrasodium [who-dd]
26. Diquafosol Tetrasodium Salt [mi]
27. Ac-36639
28. D03864
29. A900791
30. P1,p4-diuridine 5'-tetraphosphate Tetrasodium Salt
31. Q27293698
32. Uridine 5'-(pentahydrogen Tetraphosphate), P'''-5'ester With Uridine, Tetrasodium Salt
33. Uridine, 5'-(pentahydrogen Tetraphosphate), P'''-5'-ester With Uridine, Tetrasodium Salt
34. Uridine, 5'-(pentahydrogen Tetraphosphate), P''' ->5'-ester With Uridine, Tetrasodium Salt
| Molecular Weight | 878.2 g/mol |
|---|---|
| Molecular Formula | C18H22N4Na4O23P4 |
| Hydrogen Bond Donor Count | 6 |
| Hydrogen Bond Acceptor Count | 23 |
| Rotatable Bond Count | 14 |
| Exact Mass | 877.9216081 g/mol |
| Monoisotopic Mass | 877.9216081 g/mol |
| Topological Polar Surface Area | 405 Ų |
| Heavy Atom Count | 53 |
| Formal Charge | 0 |
| Complexity | 1460 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 8 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 5 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
ABOUT THIS PAGE
90
PharmaCompass offers a list of Diquafosol API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Diquafosol manufacturer or Diquafosol supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Diquafosol manufacturer or Diquafosol supplier.
PharmaCompass also assists you with knowing the Diquafosol API Price utilized in the formulation of products. Diquafosol API Price is not always fixed or binding as the Diquafosol Price is obtained through a variety of data sources. The Diquafosol Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A U2P4 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of U2P4, including repackagers and relabelers. The FDA regulates U2P4 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. U2P4 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of U2P4 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A U2P4 supplier is an individual or a company that provides U2P4 active pharmaceutical ingredient (API) or U2P4 finished formulations upon request. The U2P4 suppliers may include U2P4 API manufacturers, exporters, distributors and traders.
click here to find a list of U2P4 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A U2P4 DMF (Drug Master File) is a document detailing the whole manufacturing process of U2P4 active pharmaceutical ingredient (API) in detail. Different forms of U2P4 DMFs exist exist since differing nations have different regulations, such as U2P4 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A U2P4 DMF submitted to regulatory agencies in the US is known as a USDMF. U2P4 USDMF includes data on U2P4's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The U2P4 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of U2P4 suppliers with USDMF on PharmaCompass.
U2P4 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of U2P4 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right U2P4 GMP manufacturer or U2P4 GMP API supplier for your needs.
A U2P4 CoA (Certificate of Analysis) is a formal document that attests to U2P4's compliance with U2P4 specifications and serves as a tool for batch-level quality control.
U2P4 CoA mostly includes findings from lab analyses of a specific batch. For each U2P4 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
U2P4 may be tested according to a variety of international standards, such as European Pharmacopoeia (U2P4 EP), U2P4 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (U2P4 USP).
